IP Library Granted Patent US 7,276,535
Granted Patent B1
US 7,276,535 · App. 10/413,423 · Granted Oct 2, 2007

Intratesticular injection of chemical sterilant

Assignee: Technology Transfer, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,276,535
App. No.
10/413,423
Granted
Oct 2, 2007
Kind
B1
Abstract

A low effective dose of a biologically acceptable chemical sterilant is injected into the dorsal cranial portion of a scrotal testis of a male animal for the purpose effecting sterilization of the animal. The injection of the chemical sterilant into the dorsal cranial portion has an effect on the epithelium of the tubuli recti, rete testis and ductus efferentes in addition to stopping spermatogenesis in the seminiferous tubules.

Claims (3)

1. A method of sterilizing a male animal having scrotal testes with seminiferous tubules flowably connected to a head of an epididymis by tubuli recti, rete testis and ductuli efferentes, said method comprising locating the head of the epididymis in each testis and injecting a chemical sterilant into a dorsal cranial portion of the testis beside the head of the epididymis, said chemical sterilant being an aqueous solution of a mineral gluconate salt and an amino acid capable of forming the solution, said aqueous solution neutralized to a pH in the range of 6.0 to 7.5, said chemical sterilant injected in an amount effective to inhibit spermatogenesis and the transport of sperm through the tubuli recti, rete testis or ductuli efferentes into the head of the epididymis, said animal being a dog or a cat and the mineral gluconate salt being zinc gluconate and the amino acid being I-arginine.

2. The method of claim 1 wherein the dog is a puppy between 3 and 10 months old.

3. The method of claim 1 wherein the aqueous solution is adjusted to about pH 7.0 and contains 13.1 mg/ml zinc as zinc gluconate neutralized by 34.8 mg/ml I-arginine.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2023
From: AIPING PHARMACEUTICAL INC.
To: ARK SCIENCES, INC.
Reel/Frame 062401/0567 →
MERGER AND CHANGE OF NAME Recorded Jan 20, 2022
From: FAHIM TECHNOLOGY, INC.; ARK SCIENCES, INC.
To: ARK SCIENCES, INC.
Reel/Frame 058785/0585 →
NUNC PRO TUNC ASSIGNMENT Recorded Jan 13, 2022
From: TECHNOLOGY TRANSFER, INC.
To: FAHIM TECHNOLOGY, INC.
Reel/Frame 058646/0405 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2022
From: ARK SCIENCES, INC.
To: AIPING PHARMACEUTICAL INC.
Reel/Frame 058613/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2011
From: TECHNOLOGY TRANSFER, INC.
To: ARK SCIENCES, INC.
Reel/Frame 025917/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2003
From: WANG, MIN
To: TECHNOLOGY TRANSFER, INC.
Reel/Frame 014056/0688 →